BioCentury
ARTICLE | Financial News

Radius raises $43 million in series B

April 26, 2013 1:04 AM UTC

Radius Health Inc. (Cambridge, Mass.) raised $43 million in a series B round led by new investor F2 Biosciences. Existing investors Biotech Growth; MPM Capital; Brookside Capital; MPM Bio IV NVS Strategic Fund; and BB Biotech AG also participated. F2 Biosciences' Morana Jovan-Embiricos, and Owen Hughes, formerly a director at Brookside Capital, will join Radius' board. Hughes is now CBO and head of corporate development at diabetes company Intarcia Therapeutics (Hayward, Calif.). Last November, Radius postponed a planned IPO, citing market conditions. ...